27 min listen
A Step Forward in Treating AYA B-cell ALL With Drs. Kristen O'Dwyer and Wendy Stock
FromThe Hematologist
A Step Forward in Treating AYA B-cell ALL With Drs. Kristen O'Dwyer and Wendy Stock
FromThe Hematologist
ratings:
Length:
31 minutes
Released:
Apr 30, 2019
Format:
Podcast episode
Description
In this podcast, Contributing Editor Dr. Kristen O'Dwyer has a conversation with Dr. Wendy Stock. They discuss Dr. O'Dwyer's Diffusion article from the May/June 2019 issue of The Hematologist. The article titled, "A Step Forward in the Treatment of Adolescent and Young Adult B-cell Acute Lymphoblastic Leukemia," covers the CALGB 10403 study, a trial that tests the efficacy and feasibility of a pediatric regimen for older adolescents and young adults with newly diagnosed B- or T-lineage Philadelphia chromosome-negative acute lymphoblastic leukemia. You can find her Diffusion article online at https://www.hematology.org/Thehematologist/Diffusion/9578.aspx.
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Apr 30, 2019
Format:
Podcast episode
Titles in the series (100)
BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia: In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or sm by The Hematologist